This symposium will focus on diagnostic imaging biomarkers for age-related macular degeneration (AMD), with an emphasis on their role in disease progression. The expert panel will also provide the latest data on vitamin supplementation, which remains underutilized among eligible patients with AMD. The knowledge and skills learned will enhance your ability to diagnose and effectively manage AMD, leading to improved patient outcomes. Join us in person or virtually!
advertisement
AMD Care Simplified: Biomarkers, Progression, and the Role of Supplements
Learn from the experts on utilization of imaging biomarkers for diagnosis of AMD, plus data on the benefits of vitamins to slow disease progression.
Synchronous
Virtual Program
1.00 available credits
Information
October 9, 2025
07:30 PM - 08:30 PM ET
Virtual
Share
This broadcast will start in exactly:
- 0
Day(s)
- 0
Hour(s)
- 0
Minute(s)
- 0
Second(s)
Share
Share
Share this program on:
Details
Presenters
Faculty
Steven Ferrucci, OD, FAAO
Chief, Optometry
Sepulveda VA
Professor, SCCO at MBKU
Sepulveda, CA
Jeffry Gerson, OD, FAAO, FORS
Medical Director, Grin Eye Care
Adjunct Faculty, Western University of Health Sciences
Olathe, KS
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
Charles Retina Institute
Germantown, TNDisclosure Policy
In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Steven Ferrucci, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Bausch + Lomb, ScienceBased Health, Visible Genomics.Consultant: iCare. Speaker’s Bureau: Apellis Pharmaceuticals, Astellas, LKC Technologies.
Jeffry Gerson, OD, FAAO, FORS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, Essilor, iCare, LKC Technologies, Macular Degeneration Association, Optomed, Tarsus. Advisory Board:Allergen, Apellis Pharmaceuticals, AstaReal, Astellas, Genentech, Luneau, Notal, Optos, Regeneron, Viatris, VSP, ZeaVision.
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Apellis Pharmaceuticals, Astellas, Genentech, Regeneron, Heidelberg Engineering, OcuTerra, VirtualField, and Visible Genomics. Speaker’s Bureau: Astellas, Apellis Pharmaceuticals, Optos, and VirtualField.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.Learning Objectives
Upon completion of this activity, learners should be better able to:
- Explain the underlying mechanisms of AMD progression, highlighting the different ways in which advanced AMD can manifest
- Identify key imaging biomarkers of AMD progression that guide early diagnosis and intervention strategies
- Evaluate the use of oral supplements for patients across different stages of AMD
Target Audience
This certified continuing medical education activity is designed for optometrists.
Accreditation and Credit Designation Statements
This COPE activity has been planned and implemented in accordance with the accreditation requirements and policies of COPE through joint providership of Global Learning Collaborative and Evolve Medical Education, LLC. Global Learning Collaborative is accredited by COPE to provide continuing education to optometrists.
Global Learning Collaborative designates this synchronous virtual activity for a maximum of 1.0 COPE credit hours.
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.Grantor Statement
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.
Details
Presenters
Overview
This symposium will focus on diagnostic imaging biomarkers for age-related macular degeneration (AMD), with an emphasis on their role in disease progression. The expert panel will also provide the latest data on vitamin supplementation, which remains underutilized among eligible patients with AMD. The knowledge and skills learned will enhance your ability to diagnose and effectively manage AMD, leading to improved patient outcomes. Join us in person or virtually!
Faculty
Steven Ferrucci, OD, FAAO
Chief, Optometry
Sepulveda VA
Professor, SCCO at MBKU
Sepulveda, CA
Jeffry Gerson, OD, FAAO, FORS
Medical Director, Grin Eye Care
Adjunct Faculty, Western University of Health Sciences
Olathe, KS
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
Charles Retina Institute
Germantown, TNDisclosure Policy
In accordance with the COPE Standards for Integrity and Independence, it is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.
Steven Ferrucci, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Bausch + Lomb, ScienceBased Health, Visible Genomics.Consultant: iCare. Speaker’s Bureau: Apellis Pharmaceuticals, Astellas, LKC Technologies.
Jeffry Gerson, OD, FAAO, FORS, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, Essilor, iCare, LKC Technologies, Macular Degeneration Association, Optomed, Tarsus. Advisory Board:Allergen, Apellis Pharmaceuticals, AstaReal, Astellas, Genentech, Luneau, Notal, Optos, Regeneron, Viatris, VSP, ZeaVision.
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Apellis Pharmaceuticals, Astellas, Genentech, Regeneron, Heidelberg Engineering, OcuTerra, VirtualField, and Visible Genomics. Speaker’s Bureau: Astellas, Apellis Pharmaceuticals, Optos, and VirtualField.
The Evolve staff, planners, and peer reviewer have no financial relationships with ineligible companies.Learning Objectives
Upon completion of this activity, learners should be better able to:
- Explain the underlying mechanisms of AMD progression, highlighting the different ways in which advanced AMD can manifest
- Identify key imaging biomarkers of AMD progression that guide early diagnosis and intervention strategies
- Evaluate the use of oral supplements for patients across different stages of AMD
Target Audience
This certified continuing medical education activity is designed for optometrists.
Accreditation and Credit Designation Statements
This COPE activity has been planned and implemented in accordance with the accreditation requirements and policies of COPE through joint providership of Global Learning Collaborative and Evolve Medical Education, LLC. Global Learning Collaborative is accredited by COPE to provide continuing education to optometrists.
Global Learning Collaborative designates this synchronous virtual activity for a maximum of 1.0 COPE credit hours.
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.Grantor Statement
This activity is supported by an unrestricted educational grant from Bausch + Lomb.
Disclaimer
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Bausch + Lomb.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.ADA Statement
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Andrea Mathis prior to the live event at amathis@glc.healthcare.
Recommended
The Dry Eye Diet: Evaluating the Nutraceutical Evidence
The Dry Eye Diet: Evaluating the Nutraceutical Evidence
Live BroadcastThe Dry Eye Diet: Evaluating the Nutraceutical Evidence
Synchronous Virtual Program
07:00 PM - 08:00 PM ET
1.00 credit Learn more